Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.welcuredrugs.com | |
Market Cap | 5.04 Cr. | |
Enterprise Value(EV) | 5.28 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.00 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 37.14 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 1.05 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 3.55 | Calculated using Price: 3.73 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.35 Cr. | 13,512,100 Shares |
FaceValue | 10 | |
Company Profile | ||
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992. |
1 Day |
|
-0.77% |
1 Week |
|
-8.71% |
1 Month |
|
-7.40% |
3 Month |
|
-29.84% |
6 Month |
|
-61.16% |
1 Year |
|
-44.33% |
2 Year |
|
+93.03% |
5 Year |
|
+175.18% |
10 Year |
|
+119.21% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 108.61 | -65.80 | 17.83 | -49.46 | 131.74 | 29.03 | ||||
Return on Capital Employed (%) | 108.91 | -65.46 | 18.22 | -48.94 | 131.94 | 29.12 | ||||
Return on Assets (%) | 5.68 | 10.40 | 227.41 | 94.50 | -58.62 | 14.57 | -34.54 | 112.99 | 27.77 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Non Curr. Assets | 0 | ||||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other Income | 0 | 0 | 0 | ||||||||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash Fr. Inv. | 0 | 0 | 0 | ||||||||
Cash Fr. Finan. | |||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 10 Mar 2023
Intimation Pursuant To Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") And Amendment Thereto. This is to inform that the Company has submitted the application seeking for reclassification of the Promoters and Promoter Group to the BSE Limited in accordance with Regulation 31A of Listing Regulations and the respective checklists prescribed by the Stock Exchange on 10thMarch 2023.The Company shall keep the Stock Exchange informed in relation to the reclassification applicationin accordance with the Listing Regulations. |
Thu, 16 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication In continuation to our letter dated 14th February 2023 regarding approval of Un-Audited Financial Results for Quarter ended 31st December 2022; please find enclosed the newspaper advertisement published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 in The Pioneer (English) and Pioneer (Hindi) on 16th February 2023. |
Wed, 15 Feb 2023
Submission Of Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 With reference to the above subject the provision of the Regulation 32 of SEBI (LODR) Regulations 2015 the Statement of Deviation or Variation for proceeds of public issue rights issue preferential issue QIP is not applicable to our Company for the quarter ended 31st December 2022. |
Tue, 21 Mar 2023 |
|
|
|
|
|